VTRO — Vitro Biopharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual cashflow statement for Vitro Biopharma, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2014 October 31st	2015 October 31st	2020 October 31st	2021 October 31st	2022 October 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.247	-0.246	-1.56	-4.52	-6.86
Depreciation
Amortisation
Non-Cash Items	0.036	0.029	0.56	2.42	3.87
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.073	0.101	0.147	1	0.475
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-0.12	-0.1	-0.78	-0.998	-2.22
Capital Expenditures	-0.003	-0.012	-0.025	-0.025	-0.31
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	—	—	0	0.362	0
Sale of Business
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-0.003	-0.012	-0.025	0.337	-0.31
Financing Cash Flow Items	0.141	0.136	—	—	-1.17
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.123	0.115	0.984	4.74	-1.11
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.001	0.003	0.179	4.08	-3.64